WHO ICTRP trial
Performance of bioresorbarble scaffold in primary percutaneous intervention of…
NL-OMON43286 · Overview of Medical Research in the Netherlands (NL-OMON)
Key facts
| Trial ID | NL-OMON43286 |
|---|---|
| Public title | Performance of bioresorbarble scaffold in primary percutaneous intervention of ST elevation myocardial infarct |
| Scientific title | Performance of bioresorbarble scaffold in primary percutaneous intervention of ST elevation myocardial infarct - BVS in STEMI |
| Primary sponsor | Academisch Medisch Centrum |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Study type | Interventional |
| Countries | Netherlands ;Norway |
| Conditions | coronary artery disase. myocardial infarction;10011082;coronary artery disase. myocardial infarction |
| Interventions | Randomization between Xience metallic stent and bioresorbable scaffold ;STEMI |
| Registration date | Sep 15, 2016 |
| Target size | 10 |
| Secondary IDs | NL57201.018.16 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: